Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Parkinson's Disease

  Free Subscription

Articles published in Neuropsychology

Retrieve available abstracts of 14 articles:
HTML format

Single Articles

    July 2022
  1. CROZE R, Dilly D, Godeau M, Bouazza Z, et al
    Embodied cognition and emotion, two variables improving memory abilities in Parkinson's and Alzheimer's diseases.
    Neuropsychology. 2022 Jul 4. pii: 2022-78032-001. doi: 10.1037/neu0000826.
    PubMed     Abstract available

    June 2022
  2. TIMBLIN H, Rahmani E, Ryczek CA, Hill CR, et al
    Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson's disease.
    Neuropsychology. 2022 Jun 23. pii: 2022-74636-001. doi: 10.1037/neu0000837.
    PubMed     Abstract available

    May 2022
  3. SIQUIER A, Andres P
    Facial emotion recognition in Parkinson's disease: The role of executive and affective domains.
    Neuropsychology. 2022 May 5. pii: 2022-58801-001. doi: 10.1037/neu0000814.
    PubMed     Abstract available

    April 2022
  4. MAGGI G, Cima Munoz AM, Obeso I, Santangelo G, et al
    Neuropsychological, neuropsychiatric, and clinical correlates of affective and cognitive theory of mind in Parkinson's disease: A meta-analysis.
    Neuropsychology. 2022 Apr 7. pii: 2022-50918-001. doi: 10.1037/neu0000807.
    PubMed     Abstract available

  5. JONES JD, Valenzuela YG, Uribe C, Bunch J, et al
    Intraindividual variability in neuropsychological performance predicts longitudinal cortical volume loss in early Parkinson's disease.
    Neuropsychology. 2022 Apr 4. pii: 2022-48130-001. doi: 10.1037/neu0000809.
    PubMed     Abstract available

    March 2022
  6. CICCARELLI N, Anzuino I, Pepe F, Magni E, et al
    The facial emotion recognition deficit in Parkinson's disease: Implications of a visual scanning strategy.
    Neuropsychology. 2022 Mar 14. pii: 2022-43817-001. doi: 10.1037/neu0000802.
    PubMed     Abstract available

  7. ERIKSSON A, Tsitsi P, Vinding MC, Ingvar M, et al
    Changes in emotion processing in early Parkinson's disease reflect disease progression.
    Neuropsychology. 2022;36:206-215.
    PubMed     Abstract available

    February 2022
  8. SCHROEDERS U, Zimmermann J, Wicke T, Schaumburg M, et al
    Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson's disease.
    Neuropsychology. 2022 Feb 17. pii: 2022-33165-001. doi: 10.1037/neu0000795.
    PubMed     Abstract available

    October 2021
  9. JAEGER A, Tavares MDD, Gomide GFD, Cardoso F, et al
    Episodic memory for emotional and neutral pictures in Parkinson's disease.
    Neuropsychology. 2021 Oct 28. pii: 2021-99195-001. doi: 10.1037/neu0000779.
    PubMed     Abstract available

    July 2021
  10. PATEL SS, Muller-Oehring EM, DeVaughn S, Fama R, et al
    The effects of mood and cognition on daily functioning and quality of life in older people living with HIV and people with Parkinson's disease.
    Neuropsychology. 2021 Jul 29. pii: 2021-68507-001. doi: 10.1037/neu0000760.
    PubMed     Abstract available

  11. FIROUZI M, Baetens K, Swinnen E, Duta C, et al
    Implicit learning of perceptual sequences is preserved in Parkinson's disease.
    Neuropsychology. 2021 Jul 29. pii: 2021-68492-001. doi: 10.1037/neu0000749.
    PubMed     Abstract available

    May 2021
  12. SPARROW EP, Leung R, Statucka M, Spaniol J, et al
    Altruism in Parkinson's disease.
    Neuropsychology. 2021 May 3. pii: 2021-42257-001. doi: 10.1037/neu0000740.
    PubMed     Abstract available

  13. BARVAS E, Mattavelli G, Zappini F, Giardina F, et al
    Cognitive phenotypes in Parkinson's disease: A latent profile analysis.
    Neuropsychology. 2021;35:451-459.
    PubMed     Abstract available

    April 2021
  14. STOHLMAN SL, Barrett MJ, Sperling SA
    Factor structure of the BDI-II in Parkinson's disease.
    Neuropsychology. 2021 Apr 29. pii: 2021-40360-001. doi: 10.1037/neu0000739.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.